[Public Comment Submission] “Strategic Research and Innovation Action Plan by the European partnership on One Health AMR (Draft)” (May 30, 2024)
date : 7/12/2024
Tags: AMR
![[Public Comment Submission] “Strategic Research and Innovation Action Plan by the European partnership on One Health AMR (Draft)” (May 30, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_240530_OHAMReyecatch.jpg)
The Health and Global Policy Institute Antimicrobial Resistance (AMR) Project submitted comments on the OH AMR (The One Health AMR) Strategic Research and Innovation Agenda (SRIA) online consultation on AMR.
OH AMR is a partnership established within Horizon Europe, the European commission’s research and innovation framework program. Horizon Europe is also committed to international cooperation in OH AMR and has developed joint research programs around the world, including the EU One Health Action Plan against AMR, the Resolution on EU Action to Combat Antimicrobial Resistance, and the Council Recommendation on Stepping Up EU Actions to Combat Antimicrobial Resistance in a One Health Approach.
The SRIA was developed as a strategic action plan to promote AMR research in the EU, and the purpose of this online consultation was to obtain broad input from national and international organizations involved in AMR.
Key point of the public comments
The impact of AMR is known to be particularly widespread in the Asia-Pacific region, and given that infectious diseases including AMR can cross national borders and spread to other countries, the strengthening of AMR control measures in the Asia-Pacific region will directly lead to improved AMR control measures in the international community. Therefore, the EU should promote AMR control measures in the international community as a whole, including within the EU, by deepening cooperation with stakeholders not only in Western countries but also in the Asia-Pacific region through actively developing joint research projects and disseminating research findings.
It is imperative that each entity would fulfill its commitments to the international community in a comprehensive and integrated manner, based on the fact that infectious disease control cannot be fully implemented by countries acting alone and that each country’s interests are adjacent to those of the entire world.
For more information on these public comments, please click here.
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Suggestions for Building a Resilient and Greener Health Care System Considering Sustainability and Environmental Concerns in the Revision of Medical, Nursing Care, and Disability Welfare Service Fees (December 6, 2023)
- [Policy Recommendations] Establishing a System That Makes Full Use of Primary Care Physicians and Can Respond to Complex Chronic Pain (July 31, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Publication Report] A NAGASAKI Planetary Health Expert Meeting “From COP27 and COP15 to the G7 Hiroshima Summit: New Partnerships for Solving Climate, Environment, Biodiversity and Health Issues” Report (October 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)
-
2024-07-31
[Policy Recommendations] Establishing a System That Makes Full Use of Primary Care Physicians and Can Respond to Complex Chronic Pain (July 31, 2024)
-
2024-08-19
[Discussion Points] NCDs-related Cross-project “Lessons and Challenges Drawn from NCDs Responses in Local Governments and Future Visions” (June 17, 2024)
-
2024-08-21
[Registration Open] Online Information Session for Japan’s Patient Expert Platform (J-PEP), a Members Only Website (September 6, 2024)